Goldenwell Biotech, Inc.
GWLL
$3.00
$0.000.00%
OTC PK
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 40.11% | 34.50% | -17.41% | -12.10% | 87.66% |
| Total Depreciation and Amortization | -- | -- | -- | -- | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 88.46% | 157.89% | 308.33% | 880.00% | -- |
| Change in Net Operating Assets | 5,271.43% | 6,855.56% | -77.78% | -96.30% | -86.54% |
| Cash from Operations | 80.41% | 90.08% | -9.07% | -3.36% | 88.44% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -48.11% | -57.55% | 3.20% | -18.06% | 68.63% |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 75.00% | 75.00% | 75.00% | 75.00% | -- |
| Cash from Financing | -43.02% | -55.08% | 22.16% | -4.40% | -88.41% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 666.67% | 489.53% | 63.64% | -153.42% | 84.38% |